Cardiff Oncology (CRDF) Asset Utilization Ratio (2012 - 2026)
Cardiff Oncology (CRDF) posted Asset Utilization Ratio of 0.01 for Q4 2025, up 31.41% sequentially from 0.01 in Q3 2025, and up 10.44% YoY from 0.01 in Q4 2024.
Cardiff Oncology (CRDF) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
Cardiff Oncology has reported Asset Utilization Ratio for 14 years, with the latest figure at 0.01 in Q4 2025.
- Quarterly Asset Utilization Ratio rose 10.44% year-over-year to 0.01 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01 (up 10.44% YoY) and the FY2025 annual result came in at 0.01, down 2.4% from the prior year.
- Asset Utilization Ratio rose to 0.01 in Q4 2025 per CRDF's latest filing, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.01 in Q3 2024 and troughed at 0.0 in Q3 2021.
- A 5-year average of 0.01 and a median of 0.0 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2021 and 2024: Asset Utilization Ratio tumbled 86.09% in 2021, then jumped 135.05% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.0 in 2021, then soared by 30.4% to 0.0 in 2022, then jumped by 78.26% to 0.01 in 2023, then soared by 48.92% to 0.01 in 2024, then gained by 10.44% to 0.01 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.01, 0.01, and 0.01 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.13 |
| 10 | Cardiff Oncology | 60.21 Mn | 60.21 Mn | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |